title: Controlled human blood stage malaria infection: current status and potential applications.
abstract: Controlled human malaria infection by blood stage parasite (BSP) inoculation is an alternative to the well-established model of infection with Plasmodium falciparum sporozoites delivered by mosquito bites. The BSP model has been utilized less frequently, but its use is increasing. Advantages of BSP challenge include greater ease of administration, better standardization of the infecting dose per volunteer, and good inter-study reproducibility of in vivo parasite dynamics. Recently, a surprising reduction in clinical symptoms at microscopic patency in the BSP model has been identified, which has an undefined and intriguing pathophysiologic basis, but may make this approach more acceptable to volunteers. We summarize clinical, parasitologic, and immunologic data from all BSP challenges to date, explore differences between the BSP and sporozoite models, and propose future applications for BSP challenge.
authors.affiliation: Sir William Dunn School of Pathology, University of Oxford, United Kingdom. chrisduncan@doctors.net.uk
authors.forename: Christopher J A
authors.initials: CJ
authors.lastname: Duncan
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Draper
mesh_terms: D000818:Animals; D000852:Anopheles / Q000469:parasitology / Q000472:pathogenicity; D006801:Humans; D007299:Insect Bites and Stings / Q000469:parasitology; D017780:Malaria Vaccines / Q000276:immunology; D016778:Malaria, Falciparum / Q000097:blood* / Q000469:parasitology / Q000473:pathology* / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000254:growth & development / Q000472:pathogenicity; D034101:Sporozoites / Q000276:immunology
chemical_list: D017780:Malaria Vaccines